Regulatory Expectations for Missing Data Reporting and Analysis
Regulatory Expectations for Missing Data Reporting and Analysis How to Meet Regulatory Expectations for Missing Data in Clinical Trials Missing data in clinical trials can threaten both the credibility and regulatory acceptability of your study results. Regulatory authorities such as the USFDA, EMA, and CDSCO expect sponsors to proactively plan for, minimize, and transparently report…
Read More “Regulatory Expectations for Missing Data Reporting and Analysis” »